Taro Provides Results for September 30, 2021
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/13/2026
- Nasdaq falls ahead of earnings, economic data while oil rallies
- Oil prices rise on Saudi Arabia attacks, overshadowing Trump's diesel deal
- Will surging equity supply derail the U.S. bull market? Goldman Sachs weighs in
- Broadcom CEO says many AI investors are gamblers
- "Not buying Chipotle": Starbucks squashes blockbuster acquisition speculation
- Bausch + Lomb names Appio interim CEO as Saunders departs
- Cerebras Systems hits new 52-week low on unlock concerns
- Getty Images to go private via prepackaged Chapter 11 restructuring
- Kroger (KR) To Cut Corporate Workforce By About 3,000 Over 3 Years - Bloomberg
- Sysco calls on Teamsters to end LA strike after economic deal reached
Taro Pharma (TARO) Misses Q2 EPS by 36c
October 28, 2021 5:16 PM EDTTaro Pharma (NYSE: TARO) reported Q2 EPS of $0.66, $0.36 worse than the analyst estimate of $1.02. Revenue for the quarter came in at $132 million versus the consensus estimate of $153.23 million.
For earnings history and earnings-related data on Taro Pharma (TARO) click here.
... More


